Breast Cancer Classification Using Transfer Learning with the MobileNetV2 Architecture

Breast cancer is still one of the most commonly diagnosed cancers in the world, so detecting it early and reliably matters a great deal for patient outcomes. This paper looks at how machine learning and deep learning methods can tell benign tumors apart from malignant ones, using structured clinical and diagnostic attributes instead of raw imaging data. The model is trained and tested on patient records that include age, tumor size, lymph-node involvement and prior diagnostic history. We describe the preprocessing pipeline step by step: how the categorical diagnosis labels are encoded, how non-informative identifier fields are dropped, and how the numerical features are standardized before training. We also run an exploratory analysis of the dataset, looking at the balance between diagnosis classes, patient age groups, tumor size and breast side, so the classification results can be read against a clear picture of the data. Traditional machine learning classifiers are then compared with deep learning approaches from recent literature, and our results are discussed alongside the limitations reported by other studies. Throughout, we present the model as a decision-support tool that complements established clinical diagnosis and does not replace it.

Authors

Publication Details

Journal
International Journal of Advanced Scientific Innovation
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24298105
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Breast Cancer Classification Using Transfer Learning with the MobileNetV2 Architecture

Kotramma Mathada
1 links
International Journal of Advanced Scientific Innovation
AI in cancer detection
article

Breast Cancer Classification Using Transfer Learning with the MobileNetV2 Architecture

Kotramma Mathada
article en

Abstract

Breast cancer is still one of the most commonly diagnosed cancers in the world, so detecting it early and reliably matters a great deal for patient outcomes. This paper looks at how machine learning and deep learning methods can tell benign tumors apart from malignant ones, using structured clinical and diagnostic attributes instead of raw imaging data. The model is trained and tested on patient records that include age, tumor size, lymph-node involvement and prior diagnostic history. We describe the preprocessing pipeline step by step: how the categorical diagnosis labels are encoded, how non-informative identifier fields are dropped, and how the numerical features are standardized before training. We also run an exploratory analysis of the dataset, looking at the balance between diagnosis classes, patient age groups, tumor size and breast side, so the classification results can be read against a clear picture of the data. Traditional machine learning classifiers are then compared with deep learning approaches from recent literature, and our results are discussed alongside the limitations reported by other studies. Throughout, we present the model as a decision-support tool that complements established clinical diagnosis and does not replace it.

International Journal of Advanced Scientific Innovation
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon